|
⚲
|
| Keyboard |
| Davion Healthcare PLC | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0002039072 |
| Sale | 2026-08-26 (10.0 M Offered, 0.3 M Sold) |
| Fund | |
| Phone | 2025365191 |
| Address | Unit A Clonakilty, L2 P85 FV48 |
| Source | [EDGAR] |
| Amount Raised ($k) |
|---|
| Company Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Form D Offering | |
|---|---|
| Filed | 2026-09-08 (D) |
| Exemption | 506(b) |
| Minimum | $50,000 |
| Remaining | $9,650,000 |
| Duration | One year or less |
| Commission | $800,000 |
| Revenue | No Revenues |
| Directors | Role | 2011 - 2026 |
|---|---|---|
| Jack Kaye | Executive Officer |
| Comparable Firms | State | AUM |
|---|---|---|
|
National Bank of Canada Global Finance
✚
|
L2 | |
|
Quilter Cheviot Europe Ltd
✚
|
L2 | |
|
Irish Life Investment Managers Ltd
✚
|
L2 | |
|
Lansdowne Lothbury Master Fund Ltd
✚
|
L2 | |
|
Setanta Asset Management
✚
|
L2 | |
|
NBC Global Finance Ltd
✚
|
L2 | |
|
Lansdowne Developed Markets Long Only Master Fund Ltd
✚
|
L2 | |
|
IQ EQ Fund Management Ireland Ltd
✚
|
L2 | |
|
Gilead Therapeutics A1 Unlimited Co
✚
|
L2 | |
|
Dimensional Ireland Ltd
✚
|
L2 |